Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma

Published:2011-09-06 Issue:5 Volume:118 Page:1252-1259
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Barrios Carlos H.,Hernandez-Barajas David,Brown Michael P.,Lee Se-Hoon,Fein Luis,Liu Jin-Hwang,Hariharan Subramanian,Martell Bridget A.,Yuan Jinyu,Bello Akintunde,Wang Zhixiao,Mundayat Rajiv,Rha Sun-Young

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference28 articles.

1. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med.,2007

2. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial;Escudier;Lancet.,2007

3. Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial;Escudier;J Clin Oncol.,2009

4. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma;Hudes;N Engl J Med.,2007

5. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med.,2007

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?;Expert Review of Anticancer Therapy;2023-04-10

2. Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group;European Journal of Cancer;2022-10

3. Study on HOXBs of Clear Cell Renal Cell Carcinoma and Detection of New Molecular Target;Journal of Oncology;2021-07-08

4. Visceral Adiposity as a Significant Predictor of Sunitinib-Induced Dose-Limiting Toxicities and Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma;Cancers;2020-12-02

5. The Impact of Age and Gender on Outcomes of Patients With Advanced Renal Cell Carcinoma Treated With Targeted Therapy;Clinical Genitourinary Cancer;2020-10